Eli Lilly and Company

ERBITUX

Manufacturer:

Eli Lilly and Company

Erbitux HCPCS:

J9055

HCPCS Code Descriptor:

Injection, cetuximab, 10 mg

Category:

J Code

Erbitux NDCs:

66733-0958-23, 66733-0948-23

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Erbitux:

ERBITUX is an Oncology drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The J Code: J9055 is aligned to the drug ERBITUX.

ACCESS PRICING AND MORE BY REGISTERING

J9055 Added Date:

January 1, 2005

J9055 Effective Date:

January 1, 2005

J9055 Termination Date:

HCPCS Active

Erbitux billing and coding information can be found through Eli Lilly And Company at the link below:
Erbitux patient assistance information can be found through the Lilly Cares Foundation at the URL: http://www.lillycares.com
ERBITUX prescribing information can be found at the link below:
Information regarding ERBITUX’s side effects can be found at MedlinePlus